Crystalline forms of 6-(1H-imidazol-1-yl)-2-phenylquinazoline

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9174966
APP PUB NO 20120142713A1
SERIAL NO

13375816

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the solid state of 6-(1H-imidazol-1-yl)-2-phenylquinazoline (I) and therefore to novel crystalline forms of the base and of pharmaceutically acceptable salts and solvates thereof, and also to methods for preparing them, to the respective pharmaceutical formulations and to their therapeutic use.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ROTTAPHARM BIOTECH S R L20900 MONZA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ghirri, Matteo Milan, IT 4 38
Giordani, Antonio Pavia, IT 38 126
Mandelli, Stefano Casatenovo, IT 11 32
Porta, Francesca Milan, IT 1 0
Rovati, Lucio Claudio Monza, IT 51 122

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 3, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00